BIO-UV GROUP SAS (ALTUV.PA) Fundamental Analysis & Valuation

EPA:ALTUV • FR0013345493

Current stock price

1.3 EUR
-0.01 (-0.46%)
Last:

This ALTUV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALTUV.PA Profitability Analysis

1.1 Basic Checks

  • ALTUV had positive earnings in the past year.
  • In the past year ALTUV had a positive cash flow from operations.
  • In the past 5 years ALTUV has always been profitable.
  • Of the past 5 years ALTUV 4 years had a positive operating cash flow.
ALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFALTUV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.36%, ALTUV is doing worse than 62.62% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 2.41%, ALTUV is doing worse than 69.16% of the companies in the same industry.
  • The Return On Invested Capital of ALTUV (2.84%) is worse than 70.09% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALTUV is below the industry average of 8.48%.
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROIC 2.84%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ALTUV.PA Yearly ROA, ROE, ROICALTUV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • With a Profit Margin value of 2.64%, ALTUV perfoms like the industry average, outperforming 44.86% of the companies in the same industry.
  • ALTUV's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 5.93%, ALTUV is in line with its industry, outperforming 50.47% of the companies in the same industry.
  • ALTUV's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 38.14%, ALTUV perfoms like the industry average, outperforming 48.60% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALTUV has grown nicely.
Industry RankSector Rank
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
ALTUV.PA Yearly Profit, Operating, Gross MarginsALTUV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALTUV.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALTUV is destroying value.
  • ALTUV has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ALTUV has been increased compared to 5 years ago.
  • The debt/assets ratio for ALTUV has been reduced compared to a year ago.
ALTUV.PA Yearly Shares OutstandingALTUV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALTUV.PA Yearly Total Debt VS Total AssetsALTUV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of 1.37, we must say that ALTUV is in the distress zone and has some risk of bankruptcy.
  • ALTUV has a Altman-Z score of 1.37. This is in the lower half of the industry: ALTUV underperforms 66.36% of its industry peers.
  • ALTUV has a debt to FCF ratio of 7.69. This is a slightly negative value and a sign of low solvency as ALTUV would need 7.69 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.69, ALTUV is in line with its industry, outperforming 42.06% of the companies in the same industry.
  • ALTUV has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
  • ALTUV has a Debt to Equity ratio of 0.39. This is comparable to the rest of the industry: ALTUV outperforms 49.53% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Altman-Z 1.37
ROIC/WACC0.41
WACC6.95%
ALTUV.PA Yearly LT Debt VS Equity VS FCFALTUV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • ALTUV has a Current Ratio of 2.05. This indicates that ALTUV is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.05, ALTUV is doing good in the industry, outperforming 79.44% of the companies in the same industry.
  • ALTUV has a Quick Ratio of 1.31. This is a normal value and indicates that ALTUV is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ALTUV (1.31) is better than 74.77% of its industry peers.
Industry RankSector Rank
Current Ratio 2.05
Quick Ratio 1.31
ALTUV.PA Yearly Current Assets VS Current LiabilitesALTUV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALTUV.PA Growth Analysis

3.1 Past

  • ALTUV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 190.18%, which is quite impressive.
  • The earnings per share for ALTUV have been decreasing by -64.42% on average. This is quite bad
  • ALTUV shows a decrease in Revenue. In the last year, the revenue decreased by -7.99%.
  • Measured over the past years, ALTUV shows a quite strong growth in Revenue. The Revenue has been growing by 14.65% on average per year.
EPS 1Y (TTM)190.18%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%

3.2 Future

  • ALTUV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.91% yearly.
  • Based on estimates for the next years, ALTUV will show a small growth in Revenue. The Revenue will grow by 1.00% on average per year.
EPS Next Y-29.92%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y-1.4%
Revenue Next 3Y1%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALTUV.PA Yearly Revenue VS EstimatesALTUV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
ALTUV.PA Yearly EPS VS EstimatesALTUV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

More info and screens

Find the best growth stocksShow best growing peers

4

4. ALTUV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.57 indicates a rather expensive valuation of ALTUV.
  • ALTUV's Price/Earnings ratio is a bit cheaper when compared to the industry. ALTUV is cheaper than 68.22% of the companies in the same industry.
  • ALTUV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.23.
  • The Price/Forward Earnings ratio is 18.03, which indicates a rather expensive current valuation of ALTUV.
  • ALTUV's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.51, ALTUV is valued at the same level.
Industry RankSector Rank
PE 18.57
Fwd PE 18.03
ALTUV.PA Price Earnings VS Forward Price EarningsALTUV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ALTUV is valued a bit cheaper than 62.62% of the companies in the same industry.
  • 84.11% of the companies in the same industry are more expensive than ALTUV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.7
EV/EBITDA 8.25
ALTUV.PA Per share dataALTUV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-16.29%
EPS Next 3Y11.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. ALTUV.PA Dividend Analysis

5.1 Amount

  • ALTUV has a Yearly Dividend Yield of 2.50%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.54, ALTUV pays a better dividend. On top of this ALTUV pays more dividend than 82.24% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.90, ALTUV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.5%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
ALTUV.PA Yearly Dividends per shareALTUV.PA Yearly Dividends per shareYearly Dividends per share 2023 0 0 0 0 0

5.3 Sustainability

DP0%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
ALTUV.PA Yearly Income VS Free CF VS DividendALTUV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

More info and screens

Find the best dividend stocksShow peers with best dividend

ALTUV.PA Fundamentals: All Metrics, Ratios and Statistics

BIO-UV GROUP SAS

EPA:ALTUV (3/26/2026, 7:00:00 PM)

1.3

-0.01 (-0.46%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A
Earnings (Next)04-08
Inst Owners5.54%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.39M
Revenue(TTM)37.81M
Net Income(TTM)996.80K
Analysts86.67
Price Target2.55 (96.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.5%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.67%
PT rev (3m)-16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.57
Fwd PE 18.03
P/S 0.49
P/FCF 6.7
P/OCF 3.86
P/B 0.44
P/tB 3.59
EV/EBITDA 8.25
EPS(TTM)0.07
EY5.38%
EPS(NY)0.07
Fwd EY5.55%
FCF(TTM)0.19
FCFY14.93%
OCF(TTM)0.34
OCFY25.92%
SpS2.67
BVpS2.93
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.15
Profitability
Industry RankSector Rank
ROA 1.36%
ROE 2.41%
ROCE 3.87%
ROIC 2.84%
ROICexc 2.84%
ROICexgc 7.55%
OM 5.93%
PM (TTM) 2.64%
GM 38.14%
FCFM 7.26%
ROA(3y)1.16%
ROA(5y)1.09%
ROE(3y)2.65%
ROE(5y)2.43%
ROIC(3y)3.91%
ROIC(5y)3.06%
ROICexc(3y)4.12%
ROICexc(5y)3.44%
ROICexgc(3y)16.95%
ROICexgc(5y)12.95%
ROCE(3y)5.34%
ROCE(5y)4.18%
ROICexgc growth 3Y38.43%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.09%
ROICexc growth 5YN/A
OM growth 3Y21.79%
OM growth 5YN/A
PM growth 3Y-66.23%
PM growth 5YN/A
GM growth 3Y1.74%
GM growth 5Y3.01%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF 7.69
Debt/EBITDA 3.38
Cap/Depr 79.6%
Cap/Sales 5.35%
Interest Coverage 250
Cash Conversion 99.7%
Profit Quality 275.52%
Current Ratio 2.05
Quick Ratio 1.31
Altman-Z 1.37
F-Score7
WACC6.95%
ROIC/WACC0.41
Cap/Depr(3y)64.42%
Cap/Depr(5y)89.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)6.26%
Profit Quality(3y)6416.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)190.18%
EPS 3Y-64.42%
EPS 5YN/A
EPS Q2Q%167.3%
EPS Next Y-29.92%
EPS Next 2Y-16.29%
EPS Next 3Y11.91%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.99%
Revenue growth 3Y5.76%
Revenue growth 5Y14.65%
Sales Q2Q%-7.98%
Revenue Next Year0%
Revenue Next 2Y-1.4%
Revenue Next 3Y1%
Revenue Next 5YN/A
EBIT growth 1Y9.21%
EBIT growth 3Y28.8%
EBIT growth 5YN/A
EBIT Next Year128.57%
EBIT Next 3Y40.3%
EBIT Next 5YN/A
FCF growth 1Y112.9%
FCF growth 3Y105.52%
FCF growth 5YN/A
OCF growth 1Y18.9%
OCF growth 3Y27.9%
OCF growth 5YN/A

BIO-UV GROUP SAS / ALTUV.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BIO-UV GROUP SAS?

ChartMill assigns a fundamental rating of 4 / 10 to ALTUV.PA.


What is the valuation status of BIO-UV GROUP SAS (ALTUV.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-UV GROUP SAS (ALTUV.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for BIO-UV GROUP SAS?

BIO-UV GROUP SAS (ALTUV.PA) has a profitability rating of 4 / 10.


What is the valuation of BIO-UV GROUP SAS based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BIO-UV GROUP SAS (ALTUV.PA) is 18.57 and the Price/Book (PB) ratio is 0.44.


What is the financial health of BIO-UV GROUP SAS (ALTUV.PA) stock?

The financial health rating of BIO-UV GROUP SAS (ALTUV.PA) is 4 / 10.